In a rat model of hyperdynamic sepsis, dilation of small terminal arterioles in skeletal muscle contributes to decreased systemic vascular resistance, highlighting a potential therapeutic target.
Answers are grounded in this paper and cite their sources.
No immediate change to sepsis care; leaves open small-arteriole dilation as a therapeutic target pending human studies.
To determine the microvascular site of vasodilation during hyperdynamic sepsis, we measured arteriolar and venular responses to live Escherichia coli bacteremia in the rat cremaster muscle by direct in vivo videomicroscopy. Our data indicate that cardiac output (by thermodilution) increased, systemic vascular resistance decreased, and a differential arteriolar response occurred, with constriction of large arterioles and dilation of small terminal arterioles. We conclude that dilation of small terminal arterioles in skeletal muscle could contribute to decreased systemic vascular resistance during hyperdynamic sepsis. This may be an appropriate response to increased oxygen demand or decreased tissue utilization of oxygen. Alternatively, small-arteriole dilation may be an inappropriate response and secondary to release of vasoactive inflammatory mediators. If the latter is true, there is a potential therapeutic role for selective manipulation of the tone of small terminal arterioles in hyperdynamic sepsis.
No takes yet. Share an insight, caveat, or question.
Henry M. Cryer (1987) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: